KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Sorrento Nabs FDA Approval for Shingles Pain Patch That Could Hit Blockbuster Status February 28, 2018 The Numbers Are In: Bay Area's Depomed Reveals 328 Job Cuts in WARN Notice December 28, 2017 How Boston Scientific Is Getting Drug-Eluting Stents And Balloons Into Legs April 13, 2017
Sorrento Nabs FDA Approval for Shingles Pain Patch That Could Hit Blockbuster Status February 28, 2018
